• Income Statement
• Balance Sheet
• Cash Flow
• Ratios
• Market Data
• Valuation

	CERO THERAPEUTICS HOLDINGS, INC. (CERO)
	Q4-CY2025	Q3-CY2025	Q2-CY2025	Q1-CY2025	Q4-CY2024	Q3-CY2024	Q2-CY2024	Q1-CY2024	Q4-CY2023	Q3-CY2023	Q2-CY2023	Q1-CY2023	Q4-CY2022	Q3-CY2022	Q2-CY2022	Q1-CY2022	Q4-CY2021	Q3-CY2021	Q2-CY2021	Q1-CY2021	Q4-CY2020	Q3-CY2020	Q2-CY2020	Q1-CY2020	Q4-CY2019	Q3-CY2019	Q2-CY2019	Q1-CY2019	Q4-CY2018	Q3-CY2018	Q2-CY2018	Q1-CY2018	Q4-CY2017	Q3-CY2017	Q2-CY2017	Q1-CY2017	Q4-CY2016	Q3-CY2016	Q2-CY2016	Q1-CY2016	Q4-CY2015	Q3-CY2015	Q2-CY2015	Q1-CY2015	Q4-CY2014	Q3-CY2014	Q2-CY2014	Q1-CY2014	Q4-CY2013
Balance Sheet Date		2025-Sep-30	2025-Jun-30	2025-Mar-31	2024-Dec-31				2023-Dec-31
Fiscal Period		Q3-FY2025	Q2-FY2025	Q1-FY2025	Q4-FY2024				Q4-FY2023
Close Price of Common Stock	0.10$	4.95$	9.67$	0.70$	0.06$	0.09$	0.30$	3.09$
Market Cap of Common Stock	116,442$	5,966,740$	74,633,826$	105,684,769$	9,048,817$	4,794,888$	4,488,553$
QoQ%	(98.05%)	(92.01%)	(29.38%)	1,067.94%	88.72%	6.83%
YoY%	(98.71%)	24.44%	1,562.76%
Common Shares Outstanding	21,102,671	1,205,402	7,722,072	3,427,616	150,312,572	50,739,552	15,062,258		5,845	9,068,899	9,063,377	9,059,732
QoQ%	1,650.68%	(84.39%)	125.29%	(97.72%)	196.24%	236.87%			(99.94%)	.06%	.04%
YoY%	(85.96%)	(97.62%)	(48.73%)		2,571,543.66%	459.49%	66.19%
Price to Sales
Price to Earnings						-	-
Price to Book	-	-	-	-	-	-	-
Total Revenue							447,335$
QoQ%
YoY%
TTM
TTM_QoQ%
TTM_YoY%
Gross Margin							100.00%
QoQ
YoY
Operating Income		(4,362,579$)	(4,723,791$)	(4,950,531$)		(4,402,238$)	(5,148,237$)		(1,121,173$)	(1,535,571$)	(2,413,746$)	(2,438,346$)
QoQ%		7.65%	4.58%			14.49%			26.99%	36.38%	1.01%
YoY%		.90%	8.24%			(186.68%)	(113.29%)
TTM									(7,508,836$)
TTM_QoQ%
TTM_YoY%
Operating Margin							(1,150.87%)
QoQ
YoY
Net Income		(4,856,395$)	(5,417,315$)	(5,105,931$)		(4,227,967$)	(2,448,654$)		(1,265,182$)	(1,349,347$)	(2,092,507$)	(2,438,330$)
QoQ%		10.35%	(6.10%)			(72.67%)			6.24%	35.52%	14.18%
YoY%		(14.86%)	(121.24%)			(213.33%)	(17.02%)
TTM									(7,145,366$)
TTM_QoQ%
TTM_YoY%
Profit Margin							(547.39%)
QoQ
YoY
Equity to Common Shareholders		(4,543,162$)	(1,633,901$)	(329,386$)	(1,894,563$)	(3,702,425$)	(2,481,868$)	(3,979,097$)	(42,057,695$)				(11,000,154$)
QoQ		(2,909,261$)	(1,304,515$)	1,565,177$	1,807,862$	(1,220,557$)	1,497,229$	38,078,598$
QoQ%		(178.06%)	(396.04%)	82.61%	48.83%	(49.18%)	37.63%	90.54%
YoY		(840,737$)	847,967$	3,649,711$	40,163,132$				(31,057,541$)
YoY%		(22.71%)	34.17%	91.72%	95.50%				(282.34%)
Dividends Paid		0$	0$	127,144$
Additional Paid-In Capital QoQ		1,744,310$	(2,033,627$)	6,202,750$	778,828$	8,730,567$	3,638,158$	52,962,598$
Treasury Stock
QoQ
Goodwill
QoQ%
YoY%
Other Intangible Assets
QoQ
Amortization of Intangible Assets
Total Assets		3,911,394$	6,202,322$	7,991,414$	6,206,929$	6,491,997$	7,370,765$	9,052,656$	5,126,302$				42,367,032$
QoQ		(2,290,928$)	(1,789,092$)	1,784,485$	(285,068$)	(878,768$)	(1,681,891$)	3,926,354$
YoY		(2,580,603$)	(1,168,443$)	(1,061,242$)	1,080,627$				(37,240,730$)
Total Liabilities		8,454,556$	7,836,223$	8,320,800$	8,101,492$	10,194,422$	9,852,633$	13,031,753$	5,082,653$				39,898,341$
QoQ		618,333$	(484,577$)	219,308$	(2,092,930$)	341,789$	(3,179,120$)	7,949,100$
YoY		(1,739,866$)	(2,016,410$)	(4,710,953$)	3,018,839$				(34,815,688$)
Current Ratio		.30x	.56x	.73x	.50x	.39x	.48x	.47x	.56x
Total Current Assets		2,553,899$	4,246,566$	5,768,001$	3,714,041$	3,714,483$	4,245,911$	5,501,205$	1,970,035$
QoQ		(1,692,667$)	(1,521,435$)	2,053,960$	(442$)	(531,428$)	(1,255,294$)	3,531,170$
Total Current Liabilities		8,454,556$	7,617,915$	7,859,220$	7,402,385$	9,422,897$	8,779,323$	11,651,445$	3,507,154$				30,748,341$
QoQ		836,641$	(241,305$)	456,835$	(2,020,512$)	643,574$	(2,872,122$)	8,144,291$
Debt to Asset Ratio		2.16x	1.26x	1.04x	1.31x	1.57x	1.34x	1.44x	.99x				.94x
Long Term Debt
QoQ
YoY
Capital Lease Obligations		931,023$	1,152,618$	1,366,585$	1,575,499$	1,702,548$	1,894,628$	2,161,478$	2,344,591$
Cash and Cash Equivalents		1,900,000$	3,200,000$	5,100,000$					96,873$				475,870$
QoQ		(1,300,000$)	(1,900,000$)
YoY									(378,997$)
Interest Expenses		0$	0$	0$		0$	16,977$					(16$)
Interest Income		5,936$	13,776$	850$		4,418$	0$

Copy Table ✓